Mergers and Acquisitions
We handle some of the largest, most complex and demanding transactions in the united states and around the world.
AstraZeneca (7 billion). We advised AstraZeneca on its expansion of its alliance with Bristol-Myers Squibb (BMS) through BMS’ acquisition of Amylin Pharmaceuticals, a San Diego, California-based biopharmaceutical company.
EQT Partners (2.2 billion). We advised EQT Partners, a Swedish private equity firm, on its sale of Dako, a Danish tissue-based diagnostics company, to Agilent Technologies, a Santa Clara, California–based provider of measurement technology for chemical analysis and life sciences applications.
Edwards Group (1.6 billion). We have advised Edwards Group, a United Kingdom based developer and manufacturer of sophisticated vacuum products, abatement systems and other related value-added services, on its $1.6 billion acquisition, pending specific earnouts, by Atlas Copco, a Swedish manufacturer of compressors, expanders and air treatment systems, construction and mining equipment, power tools and assembly systems.
Taylor Wimpey (955 million). We advised Taylor Wimpey, a homebuilder, in connection with the sale of its US and Canadian business to TMM Holdings, a partnership controlled by certain investment funds affiliated with TPG Capital, certain investment funds affiliated with Oaktree Capital Management and JH Investments.
Delonex Energy (700 million). We have advised Delonex Energy, a new, world-class energy exploration and production company focused on Central and East Africa with headquarters in London, in connection with a $700 million investment by an affiliate of Warburg Pincus, a global private equity firm with more than $40 billion in assets under management.
ARM (350 million). We advised ARM Holdings, a United Kingdom developer and supplier of semiconductor intellectual property, on its leading participation in a consortium of major technology companies affiliated with Allied Security Trust that acquired the rights to MIPS Technologies’ patent portfolio for $350 million, of which ARM will contribute $168 million. The MIPS patent portfolio includes five-hundred patent applications covering microprocessor design, system-on-chip design and other related technology fields.